Katherine V Stultz
CIK 1864500 · CHIEF OPERATING OFFICER · last filed 2025-06-20
Katherine V Stultz is a CHIEF OPERATING OFFICER who has filed 5 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for KRON, was dated Jun 20, 2025.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
5
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Kronos Bio, Inc. (KRON) Delisted | Director | — | $0.88 | — | $0 | 4 | 2025-06-20 |
| LENZ Therapeutics, Inc. (GRPH) Delisted | CHIEF OPERATING OFFICER | 216,020 | $22.26 | $4.81M | $0 | 1 | 2021-07-01 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-20 | Kronos Bio, Inc. (KRON) Delisted | Disp (D) | — | $0 | EDGAR |
| 2024-06-26 | Kronos Bio, Inc. (KRON) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-26 | Kronos Bio, Inc. (KRON) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-04-11 | Kronos Bio, Inc. (KRON) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-07-01 | LENZ Therapeutics, Inc. (GRPH) Delisted | Mixed | +8,126 | $0 | EDGAR |